Treatment-Resistant Infections More Common Among Nursing Home Ventilator Patients: Study

In some cases, nursing home patients on ventilators were several times more likely to develop treatment-resistant infections than those on ventilators in hospitals.

Patients on ventilators in long-term care facilities, such as nursing homes, are more likely to test positive for antibiotic-resistant infections than patients in hospitals, according to the findings of a new study.

Ventilators can often spread infections because they mechanically pump air for a patient, which can contain infections agents. Pneumonia infections are most common, but other infections can also occur.

In a study published on October 12 in the Journal of the American Medical Association (JAMA), researchers from the University of Maryland School of Medicine say patients in long-term care facilities put on ventilators were more likely to carry colonies of so-called “superbugs” that resist antibiotic treatment than patients given the same treatment in hospitals.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

The findings involved a review of data from the Maryland Multi-Drug Resistant Organism Prevention Collaborative study, a statewide cross-sectional study of patients receiving mechanical ventilation admitted to acute care hospitals and long-term care facilities from March 2023 to June 2023. The study included nearly 500 patients in 33 hospitals and 18 long-term care facilities.

Researchers took surveillance cultures from all patients receiving mechanical ventilation in both hospital and long-term care facilities. Samples were taken from saliva, perianal, arm, leg, and groin areas.

Nursing Home Antibiotic-Resistant Infection Risks

According to the findings, Patients in long-term care facilities were more likely to be colonized with Acinetobacter baumannii, carbapenem-resistant A baumannii (CRAB), and Candida auris, compared with patients in hospitals.

Overall, a. baumannii was identified in 31% of patients. Of those, 60% were CRAB, a superbug that is resistant to treatment.  In addition, 7% tested positive for Candida auris.

However, patients in long-term care facilities were nearly eight times more likely to be colonized with A. baumannii, five and a half times more likely to carry CRAB colonies, and twice as likely to be carriers of C. auris than those in acute care hospitals.

Patients in long-term facilities needing ventilation often face more severe health issues. They may be in a coma or suffer a serious infection requiring ventilation, and conditions like COVID-19 can require mechanical ventilation when the patient has trouble breathing on their own.

Emerging Treatment-Resistant Infection Threats

C. auris is a potentially lethal fungus that is resistant to treatment. It primarily infects people with weakened immune systems and the elderly. The fungus is generally not a threat to healthy people.

However, those who are sick, have long, frequent stays in healthcare facilities, including nursing homes, or have had invasive medical devices implanted surgically are considered a high-risk group.

Both C. auris and A baumannii are considered emerging threats, since more and more cases are being discovered, and treatment is difficult.

The U.S. Centers for Disease Control and Prevention issued a warning in March about the growing threat of C. auris and more than 7,000 cases reported across 20 states.

Another study from earlier this year warned C. auris infections are spreading from hospital to hospital throughout the U.S. The rapid spread of the fungus is plaguing healthcare facilities that struggle to detect and treat patients affected by the fungus.

The new study focused on all patients receiving mechanical ventilation in Maryland in both types of facilities. But only one statewide survey has been performed for A baumannii in the U.S. and no studies on the burden of C. auris have been performed.

Researchers recommend this same study should be conducted in other states, to determine what the true threat may be among patients receiving mechanical ventilation. They also called for increased surveillance and prevention efforts, especially at long-term care facilities like nursing homes.

“Patients receiving mechanical ventilation in long-term care facilities are a high-risk population for emerging pathogens, and surveillance and prevention efforts should be targeted to these facilities,” the researchers concluded.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

AFFF Ulcerative Colitis Lawsuit Filed Over Contaminated Water in Colorado Springs
AFFF Ulcerative Colitis Lawsuit Filed Over Contaminated Water in Colorado Springs (Posted today)

Lawsuit blames PFAS manufacturers for failing to prevent water contamination by their chemicals, or warn municipalities and the public about the potential risks of ulcerative colitis and other diseases as a result of exposure.

Port Catheter Infection Lawsuits Over Bard PowerPort Devices Claim Faulty Design Promotes Colonization of Bacteria
Port Catheter Infection Lawsuits Over Bard PowerPort Devices Claim Faulty Design Promotes Colonization of Bacteria (Posted yesterday)

Hundreds of currently pending Bard PowerPort lawsuits over infections, fractures and migration injuries were consolidated into a multidistrict litigation (MDL), but now even more claims present similar allegations that the implantable port catheter system has dangerous design defects that were not adequately disclosed by the manufacturer.

Johnson & Johnson Increases Talcum Powder Settlement Offer by $1.1B: Reuters
Johnson & Johnson Increases Talcum Powder Settlement Offer by $1.1B: Reuters (Posted yesterday)

A recent report suggests that Johnson & Johnson is offering an additional $1.1 billion to settle talcum powder lawsuits, as part of a proposed $9 billion deal that would resolve all ovarian cancer claims as part of a third bankruptcy filing by the manufacturer.